Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 211 posts found.

Lilly image

Lilly plans trio of launches

October 4, 2013
Research and Development, Sales and Marketing lilly, pipeline

Lilly plans to launch at least three new medicines next year, senior managers announced during a meeting with analysts and …

News
lilly_outside_plaque

Lilly drawn into China bribery scandal

August 22, 2013
Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery, corruption, lilly, payments

News
Lilly image

Phoenix from the flames for Lilly cancer drug

August 14, 2013
Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …

News
Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

News
lilly image

Transition Therapeutics buys into Lilly bone drug

July 24, 2013
Research and Development, Sales and Marketing Transition, bone, lilly

Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …

News
lilly image

Lilly revisits Alzheimer’s drug

July 15, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …

News
evista image

NICE finalises tamoxifen guidance

June 26, 2013
Sales and Marketing Evista, NICE, lilly, tamoxifen

Women at risk of breast cancer can now be offered a daily pill on the NHS to stop the disease …

News
Lilly image

Lilly diabetes drug beats rivals

June 25, 2013
Sales and Marketing BMS, diabetes, dulaglutide, lilly

New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …

News
Lilly image

Lilly pays Transition $7 million

June 19, 2013
Research and Development, Sales and Marketing Transition, lilly

Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …

News
Go dad run image

Lilly UK sponsors ‘Go Dad Run’ charity

June 6, 2013
Medical Communications go dad run, lilly, prostate

Lilly is sponsoring Olympic hurdler Colin Jackson’s ‘Go Dad Run’, a new 5k run for men to raise awareness of …

News
Complications combat image

Boehringer and Lilly launch diabetes game

June 4, 2013
Medical Communications Boehringer Ingelheim, combat, lilly

Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …

News
Roche image

Lilly and Roche back US research institute

May 31, 2013
Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …

News

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013
Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

News
Lilly image

Lilly takes $30m hit

May 13, 2013
Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …

News
lilly_corporate_hq

Zyprexa decline hits Lilly

April 26, 2013
Sales and Marketing Q1, lilly, zyprexa

Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026